Critical challenges and emerging opportunities in hepatitis C virus research in an era of potent antiviral therapy: considerations for scientists and funding agencies
Please log in to take part in the discussion (add own reviews or comments).
Cite this publication
More citation styles
- please select -
%0 Journal Article
%1 noauthororeditor101016jvirusres201802016
%A Bartenschlager, R
%A Baumert, T F
%A Bukh, J
%A Houghton, M
%A Lemon, S M
%A Lindenbach, B D
%A Lohmann, V
%A Moradpour, D
%A Pietschmann, T
%A Rice, C M
%A Thimme, R
%A Wakita, T
%D 2018
%E Res, Virus
%J Virus Res
%K pietschmann
%P 53-62
%T Critical challenges and emerging opportunities in hepatitis C virus research in an era of potent antiviral therapy: considerations for scientists and funding agencies
%V 248:
@article{noauthororeditor101016jvirusres201802016,
added-at = {2018-02-28T14:37:43.000+0100},
author = {Bartenschlager, R and Baumert, T F and Bukh, J and Houghton, M and Lemon, S M and Lindenbach, B D and Lohmann, V and Moradpour, D and Pietschmann, T and Rice, C M and Thimme, R and Wakita, T},
biburl = {https://www.bibsonomy.org/bibtex/206c3cbdd1ff23796824c2b7cbb02807d/pietschmann},
editor = {Res, Virus},
interhash = {6420085a1a64cef4b88230426071ff2b},
intrahash = {06c3cbdd1ff23796824c2b7cbb02807d},
journal = {Virus Res},
keywords = {pietschmann},
pages = {53-62},
pubmedurl = {https://www.ncbi.nlm.nih.gov/pubmed/29477639},
timestamp = {2019-10-14T09:58:11.000+0200},
title = {Critical challenges and emerging opportunities in hepatitis C virus research in an era of potent antiviral therapy: considerations for scientists and funding agencies},
volume = {248:},
year = 2018
}